Literature DB >> 21804851

Low-Dose Risperidone-Induced Oculogyric Crises in an Adolescent Male with Autism, Tourette's and Developmental Delay.

Tamara Masliyah1, Yasser Ad-Dab'bagh.   

Abstract

This article will review the case of a young patient with mental retardation, autistic disorder, and Tourette Syndrome who exhibited a favourable treatment response preferentially to risperidone. His presentation, however, was complicated by an exquisite sensitivity to risperidone displayed in the form of recurrent oculogyric crises. In this article, we will outline a review of the case, a survey of the incidence and risk factors of oculogyric crises, as well as a review of the literature on risperidone sensitivity, followed by a review of alternate options for the prevention of oculogyric crises.

Entities:  

Keywords:  Tourette Syndrome; autistic disorder; dystonic reaction; mental retardation; oculogyric crisis

Year:  2011        PMID: 21804851      PMCID: PMC3143698     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  10 in total

Review 1.  Acute dystonia induced by drug treatment.

Authors:  P N van Harten; H W Hoek; R S Kahn
Journal:  BMJ       Date:  1999-09-04

2.  Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.

Authors:  R Friedlander; S Lazar; J Klancnik
Journal:  Can J Psychiatry       Date:  2001-10       Impact factor: 4.356

3.  Tourette syndrome and dystonia.

Authors:  Tamara Pringsheim; Roger Freeman; Anthony Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

4.  Acute and long-term safety and tolerability of risperidone in children with autism.

Authors:  Michael G Aman; L Eugene Arnold; Christopher J McDougle; Benedetto Vitiello; Lawrence Scahill; Mark Davies; James T McCracken; Elaine Tierney; Patricia L Nash; David J Posey; Shirley Chuang; Andres Martin; Bhavik Shah; Nilda M Gonzalez; Naomi B Swiezy; Louise Ritz; Kathleen Koenig; James McGough; Jaswinder K Ghuman; Ronald L Lindsay
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-12       Impact factor: 2.576

5.  Acute dystonic reaction with risperidone.

Authors:  J Takhar; R Manchanda
Journal:  Can J Psychiatry       Date:  1996-02       Impact factor: 4.356

6.  Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.

Authors:  M Fayen; M B Goldman; M A Moulthrop; D J Luchins
Journal:  Am J Psychiatry       Date:  1988-04       Impact factor: 18.112

7.  Acute dystonia with low-dosage aripiprazole in Tourette's disorder.

Authors:  Konstantinos N Fountoulakis; Melina Siamouli; Sotiris Kantartzis; Panagiotis Panagiotidis; Apostolos Iacovides; George St Kaprinis
Journal:  Ann Pharmacother       Date:  2006-03-28       Impact factor: 3.154

8.  High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity.

Authors:  Gara L Coffey; Sheila R Botts; Jose de Leon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-06       Impact factor: 5.067

Review 9.  Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature.

Authors:  A H Németh; K R Mills; J S Elston; A Williams; E Dunne; N M Hyman
Journal:  Mov Disord       Date:  1999-09       Impact factor: 10.338

Review 10.  Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.

Authors:  John M Kane
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

  10 in total
  1 in total

1.  Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome.

Authors:  Piotr Janik; Monika Figura
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-25       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.